FDMT 4D MOLECULAR THERAPEUTICS IN
FollowStock (common), issuer CIK 1650648
Filings received so far for Q3 2026: 5 13F filers report a position in FDMT shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Kirn Daviddirector, officer (See Remarks) | 2026-10-05 | -272 S | $13.6104 | Form 4 |
| Kirn Daviddirector, officer (See Remarks) | 2026-10-05 | -58,061 S | $12.9215 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| TOTH FINANCIAL ADVISORY CORP | 2,000 | $28.6K | <0.01% | new | 13F-HRTimeline |
| GAMMA Investing LLC | 1,543 | $22.1K | <0.01% | +209 | 13F-HRTimeline |
| Versant Capital Management, Inc | 728 | $10.4K | <0.01% | 0 | 13F-HRTimeline |
| Planning Strategies Inc. | 502 | $7.18K | <0.01% | 0 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 125 | $1.79K | <0.01% | 0 | 13F-HRTimeline |
Events
Kirn David sold 58,333 FDMT shares on 2026-10-05, Form 4 filed 2026-10-07. 0001193125-26-417068
Accepted , ingested